Production, crystallization and X-ray diffraction analysis of a complex between a fragment of the TssM T6SS protein and a camelid nanobody

Acta Crystallographica. Section F, Structural Biology Communications
Van Son NguyenAlain Roussel

Abstract

The type VI secretion system (T6SS) is a machine evolved by Gram-negative bacteria to deliver toxin effectors into target bacterial or eukaryotic cells. The T6SS is functionally and structurally similar to the contractile tail of the Myoviridae family of bacteriophages and can be viewed as a syringe anchored to the bacterial membrane by a transenvelope complex. The membrane complex is composed of three proteins: the TssM and TssL inner membrane components and the TssJ outer membrane lipoprotein. The TssM protein is central as it interacts with both TssL and TssJ, therefore linking the membranes. Using controlled trypsinolysis, a 32.4 kDa C-terminal fragment of enteroaggregative Escherichia coli TssM (TssM32Ct) was purified. A nanobody obtained from llama immunization, nb25, exhibited subnanomolar affinity for TssM32Ct. Crystals of the TssM32Ct-nb25 complex were obtained and diffracted to 1.9 Å resolution. The crystals belonged to space group P64, with unit-cell parameters a = b = 95.23, c = 172.95 Å. Molecular replacement with a model nanobody indicated the presence of a dimer of TssM32Ct-nb25 in the asymmetric unit.

References

Jun 3, 1993·Nature·C Hamers-CastermanR Hamers
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Sep 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Stefan PukatzkiJohn J Mekalanos
Sep 23, 2008·Journal of Bacteriology·Marie-Stéphanie AschtgenEric Cascales
Jan 9, 2010·Acta Crystallographica. Section D, Biological Crystallography·Alexei Vagin, Alexei Teplyakov
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
May 22, 2010·Molecular Microbiology·Marie-Stéphanie AschtgenEric Cascales
Jul 24, 2010·Toxins·Karla J F Satchell
Dec 24, 2010·Virulence·Marie-Stéphanie AschtgenEric Cascales
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Martyn D WinnKeith S Wilson
Nov 29, 2011·Acta Crystallographica. Section D, Biological Crystallography·Vincenzo A RaoWilliam N Hunter
Mar 14, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Eric Cascales, Christian Cambillau
Apr 17, 2012·Journal of Molecular Biology·Craig S RobbAlisdair B Boraston
Aug 18, 2012·The Journal of Biological Chemistry·Eric DurandChristian Cambillau
Mar 19, 2013·Annual Review of Biochemistry·Serge Muyldermans
Mar 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Aline DesmyterChristian Cambillau
Apr 2, 2013·Research in Microbiology·Sarah J Coulthurst
Dec 18, 2013·Cell Host & Microbe·Brian T HoJohn J Mekalanos
Jan 5, 2014·Nature Reviews. Microbiology·Alistair B RussellJoseph D Mougous
Mar 1, 2014·Nature Protocols·Els PardonJan Steyaert
Apr 1, 2014·Biochimica Et Biophysica Acta·Abdelrahim ZouedEric Cascales
Jul 22, 2014·Trends in Microbiology·Eric DurandLaure Journet

❮ Previous
Next ❯

Citations

Mar 27, 2015·PloS One·Van Son NguyenChristian Cambillau
Jul 23, 2015·Nature·Eric DurandRémi Fronzes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.